Trial intelligence / Profile preview

Ketorolac for Pain Control at Oocyte Retrieval

NCT06026553Phase 1Unknown

Sponsor
Shady Grove Fertility
Start
Aug 2022
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in postoperative pain comparing Ketorolac with Placebo (2 arms). Primary endpoint: Administration of IV narcotic for rescue analgesia during recovery in the post anesthesia care unit (PACU). Status: unknown.

02

Drugs

ketorolac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06026553.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06026553.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call